Investor

CHL Medical Partners

Last cheque observed Aug 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series BSeries CSeries AMedical

Cheques on record
0%of best year0cheques in 12 months, 30 on record
Since the last cheque4466days00hrs00min00sec
Median round$20MRounds led0 of 30Sole investor1 roundsExits4 from the portfolioMostly inUnited States, 100%
Pitch CHL Medical Partners

CHL Medical Partners highlights

  1. 01

    30 rounds on record

  2. 02

    Mostly Series B and Series C: 50% of its rounds

  3. 03

    Sole investor in 1 rounds, median $33M

  4. 04

    4 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
Medical
Cold pitches
Not stated

The record

Every round we can evidence, newest first30 appearances

  1. 2014

    2 rounds

  2. Aug
    Mevion Medical SystemsGrowth · US$200MWith 5 others
  3. Jun
    Vascular PathwaysDebt · US$5.0MWith 3 others
  4. 2013

    1 round

  5. Jun
    Mevion Medical SystemsGrowth · US · finsmes.com$55MWith 3 others
  6. 2012

    4 rounds

  7. Jul
    CareWell Urgent CareSeries A$7.0MWith 1 other
  8. May
    DICOM GridSeries B · US · pevc.dowjones.com$5.0MWith 1 other
  9. Mar
    OpGenSeries C · US · finsmes.com$17MWith 5 others
  10. Jan
    Mevion Medical SystemsVenture · US · mevion.com$45MWith 2 others
  11. 2011

    1 round

  12. Sept
    ValeritasSeries C · US · finsmes.com$150MWith 8 others
  13. 2010

    4 rounds

  14. Nov
    DICOM GridSeries A · US · finsmes.com$7.5MWith 1 other
  15. Nov
    Vascular PathwaysSeries B · US · finsmes.com$14MWith 3 others
  16. Sept
    OpGenSeries B · US · opgen.com$17MWith 4 others
  17. Jan
    Vertos MedicalSeries D · US · onbiovc.com$16MWith 4 others
  18. 2009

    3 rounds

  19. Oct
    PrimeraDx (Primera Biosystems)Series C · US · onbiovc.com$20MWith 5 others
  20. Jun
    VaxInnateSeries D · US · onbiovc.com$30MWith 6 others
  21. Jan
    Mevion Medical SystemsVenture · US · bio-medicine.org$33MSole investor
  22. 2008

    3 rounds

  23. Jul
    Vertos MedicalSeries C · US$12MWith 2 others
  24. Jan
    North American ScientificVenture$16MWith 2 others
  25. Jan
    POINT BiomedicalSeries E · US$25MWith 5 others
  26. 2007

    6 rounds

  27. Nov
    BIKAM PharmaceuticalsSeries A$11MWith 1 other
  28. Oct
    Mevion Medical SystemsSeries C · US$6.9MWith 2 others
  29. Sept
    OpGenSeries A · US · opgen.com$24MWith 4 others
  30. Jun
    Millennium Pharmacy SystemsGrowth · US$40MWith 3 others
  31. Jun
    BioRelixSeries A · US · masshightech.com$26MWith 5 others
  32. Mar
    Ascend HealthSeries B · US$20MWith 2 others
  33. 2006

    1 round

  34. Oct
    VaxInnateSeries C · US · thefreelibrary.com$40MWith 5 others
  35. 2005

    1 round

  36. Dec
    Resolvyx PharmaceuticalsSeries A · US$17MWith 2 others
  37. 2004

    3 rounds

  38. May
    Amicus TherapeuticsSeries B · US$31MWith 5 others
  39. Mar
    VaxInnateSeries B · US$23MWith 3 others
  40. Jan
    Threshold PharmaceuticalsSeries B · US$41MWith 6 others
  41. 2001

    1 round

  42. Jul
    RxCentricSeries C · US$5.0MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed4 in all

Millennium Pharmacy SystemsBought by PharMerica CorporationUndisclosedOct 2014
Ascend HealthBought by Universal Health ServicesUndisclosedJun 2012
Threshold PharmaceuticalsListedUndisclosedJan 2005
RxCentricBought by AllscriptsUndisclosedAug 2003

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as CHL Medical Partners. A count of rooms they were both in, not a relationship either has claimed.

CanaanVC firm5rounds togetherHealthCare VenturesGrowth equity4rounds togetherProQuest InvestmentsVC firm4rounds togetherVenrockVC firm4rounds togetherCaxton Advantage Life Sciences FundGrowth equity3rounds togetherHighland Capital PartnersVC firm3rounds togetherMedImmune VenturesCorporate VC3rounds togetherNew Leaf Venture PartnersVC firm3rounds togetherOxford Bioscience PartnersGrowth equity3rounds togetherThree Arch PartnersGrowth equity3rounds togetherVersant VenturesVC firm3rounds togetherAbingworthVC firm2rounds together

Quick answers about CHL Medical Partners

What does CHL Medical Partners invest in?

CHL Medical Partners invests most often at Series B and Series C (50% of the rounds on record), in sectors such as Medical.

How active is CHL Medical Partners?

30 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2014.

How big are CHL Medical Partners's cheques?

The median round it joins is $20M.

Does CHL Medical Partners lead rounds?

Rarely, if at all: none of its 30 investments on record names it as the lead.

Where does CHL Medical Partners invest?

Most of the companies it backs are in the United States (100%).

Is CHL Medical Partners investing now?

No investments in the last 12 months; the latest was in Aug 2014.

Who does CHL Medical Partners invest alongside?

Most often Canaan (5 rounds together), HealthCare Ventures (4 rounds together) and ProQuest Investments (4 rounds together).

What kind of investor is CHL Medical Partners?

CHL Medical Partners is a VC firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it